tcell
play
crucial
role
immun
surveil
transform
cell
intracellular
infect
involv
autoimmun
reaction
recogn
target
ie
mhc
peptid
complex
trough
tcell
receptor
tcr
usag
determin
molecular
interact
immun
system
biolog
relev
mhcpeptid
molecul
tcr
code
gene
variabl
divers
junction
determin
molecular
composit
tcr
alpha
beta
heterodim
random
associ
vdj
gene
constitut
complementar
determin
region
respons
antigen
recognit
tcr
specif
molecular
composit
tcell
popul
object
defin
measur
region
qualit
quantit
comparison
tcr
composit
differ
anatom
compart
longitudin
time
allow
ass
entir
tcr
repertoir
methodolog
supplement
function
tcell
base
assay
aid
object
describ
alter
tcell
pool
tcr
analysi
use
immunomonitor
eg
examin
patient
bmt
solid
organ
transplant
patient
haart
therapi
patient
receiv
molecularli
defin
vaccin
tcell
respons
ie
number
respond
tcell
within
popul
iii
molecular
qualiti
tcell
molecular
structur
defin
tcell
receptor
tcr
structur
sever
method
measur
tcell
respons
avail
includ
evalu
tcell
precursor
use
limit
dilut
elispot
assay
ex
vivo
tcell
receptor
tcr
variabl
v
segment
analysi
determin
flow
cytometri
length
analysi
spectratyp
well
identif
peptidespecif
tcell
use
mhc
class
mhc
class
ii
tetram
contain
appropri
peptid
tcell
respons
molecularli
defin
identif
monoclon
tcell
receptor
known
bind
defin
peptid
target
present
appropri
mhc
molecul
ii
gaug
tcell
popul
mono
oligoor
polyclon
defin
tcell
receptor
tcr
famili
tcell
popul
data
aid
defin
compar
magnitud
tcell
respons
time
individu
patient
either
result
progressionregress
certain
diseas
altern
alter
tcell
pool
associ
treatment
compar
molecular
composit
tcr
tcr
tcell
time
differ
anatom
compart
compar
tcr
vavb
tcr
vdvg
divers
normal
healthi
control
molecular
fingerprint
tcrrepertoir
correct
qualit
assess
individu
tcr
vb
famili
tcr
fingerprint
object
describ
tcr
composit
given
sampl
pure
descript
measur
complement
use
function
methodolog
tcr
analysi
individu
tcell
subpopul
defin
differenti
home
marker
tcell
defin
cytokin
product
respons
antigen
interest
tcell
defin
mhcpeptidespecif
determin
tetram
tcr
nomenclatur
adapt
latest
issu
cell
receptor
factsbook
four
type
gene
involv
tcr
synthesi
variabl
v
divers
join
j
gene
code
antigen
mhc
bind
site
constant
c
gene
encod
nonvari
tcr
polypeptid
chain
tcr
locu
group
tcr
gene
order
organ
chromosom
locat
given
ie
human
speci
human
genom
encod
four
tcr
loci
tra
trb
trg
trd
embed
within
locu
see
group
group
tcr
gene
share
gene
type
ie
v
j
subgroup
set
gene
belong
group
share
least
ident
nucleotid
level
germlin
configur
v
j
eg
tcr
vb
famili
also
practic
relev
sinc
primer
implement
analysi
may
encompass
sever
subgroup
rtpcr
primer
need
cover
individu
tcr
v
gene
defin
tcr
bind
region
tcell
receptor
fingerprint
measur
length
complementar
determin
region
figur
case
rearrang
tcr
loci
result
delet
join
v
gene
local
upstream
j
c
gene
two
gene
recombin
activ
gene
identifi
transcrib
lymphocyt
show
recombinas
activ
ie
b
tcell
gene
exceptionsonli
activ
thymic
tissu
pertain
tlymphocyt
junction
divers
respons
creation
tcr
divers
associ
antigen
recognit
ie
mhcpeptid
complex
nregion
divers
result
delet
nucleotid
extrem
code
v
j
gene
activ
exonucleas
random
addit
nucleotid
termin
deoxynucleotidyl
transferas
tdt
enzym
preferenti
add
g
c
nucleotid
junction
specif
transcrib
lymphocyt
matur
region
determin
complementar
determin
region
brief
specif
tcell
resid
region
length
region
defin
divers
tcr
repertoir
region
human
measur
approxim
amino
acid
residu
ie
base
pair
show
gaussdistribut
abund
transcript
measur
approxim
amino
acid
residu
see
figur
c
group
may
contain
fu
f
f
nctional
tcr
tcr
pseudogen
major
middl
peak
bp
peak
left
right
side
respect
typic
gauss
distribut
aa
code
area
note
peak
identifi
base
pair
code
one
amino
acid
residu
singl
peak
may
suggest
monoclon
confirm
dna
sequenc
analysi
sinc
even
singl
peak
one
amino
acid
residu
indic
length
region
amino
acid
residu
howev
differ
amino
acid
residu
may
possibl
composit
defin
tcr
vb
pool
may
either
poli
oligoor
monoclon
see
figur
estim
theoret
possibl
tcr
repertoir
use
human
tcell
human
peripher
blood
carri
differ
tcr
vb
chain
note
studi
avail
today
address
question
tcr
divers
tcr
vb
chain
base
presumpt
individu
tcell
express
singl
tcr
va
chain
pair
singl
tcr
vb
chain
true
tlymphocyt
peripher
circul
although
doubl
tcr
vb
chain
pair
singl
tcr
va
chain
vice
versa
report
studi
address
molecular
composit
gamma
delta
tcell
may
also
play
role
autoimmun
diseas
confer
resist
infect
antitumor
immun
respons
time
indic
tcr
gene
somat
alter
tcr
divers
gener
germlin
configur
determin
tcr
specif
thu
length
tcr
region
describ
detail
tcr
divers
identifi
cell
count
absolut
cell
count
determin
carri
estim
number
tcell
sampl
studi
perform
use
entir
peripher
blood
tcell
pbl
may
allow
detect
monoclon
tcell
popul
tcell
subset
sinc
eg
monoclon
tcr
singl
vb
famili
tcell
popul
may
mask
polyclon
tcr
tcell
popul
sampl
addit
true
number
tcell
determin
combin
absolut
cell
count
sampl
combin
flowcytometr
analysi
tcr
alphabetaposit
tcell
treatment
diseas
may
associ
skew
composit
tcell
popul
gener
applic
tcr
fingerprint
measur
composit
tcr
beta
chain
tcr
tcell
expans
tcr
tcell
neither
pick
lymphocyt
count
measur
tcell
sinc
tcr
tcr
cell
determin
cell
number
crucial
sinc
cell
number
analyz
longitudin
studi
ii
associ
sensit
tcr
fingerprint
assay
laboratori
use
methodolog
run
appropri
control
ensur
tcr
vfamili
identifi
use
appropri
primer
panel
figur
show
use
suboptim
cell
number
lead
falseposit
monoclon
individu
tcr
variabl
famili
may
associ
primer
panel
use
amplif
tcr
famili
sensit
number
tcr
transcript
tcr
famili
differ
way
standard
sampl
possibl
standard
cell
number
either
pbl
sort
tcell
standard
mrna
transcript
sampl
use
housekeep
gene
gene
share
tcr
famili
eg
measur
tcr
constant
chain
tcell
sort
tcell
least
puriti
obtain
tcell
popul
tcell
popul
tcell
may
also
includ
dendrit
cell
macrophag
laboratori
assess
sensit
specif
tcr
analysi
crucial
order
avoid
fals
positiveneg
result
ensur
high
standard
monitor
tcr
transcript
longitudin
clinic
trial
tcr
analysi
allow
determin
structur
composit
address
quantiti
tcr
vb
ie
absolut
number
tcell
examin
tcr
divers
sever
way
gaug
tcell
possibl
first
protein
express
tcr
determin
flow
cytometri
entir
tcell
repertoir
cover
use
panel
tcrspecif
mab
altern
mrna
transcript
measur
tcr
vb
famili
methodolog
possibl
cell
suspens
applic
tissu
section
thu
tcrrepertoir
pbl
compar
tissu
eg
tumor
section
lymph
node
latter
approach
use
standard
tcr
mrna
perform
addit
tcr
cell
surfac
express
determin
flowcytometri
may
provid
differ
result
compar
tcr
mrna
analysi
activ
tcell
may
downregul
tcr
enhanc
tcr
mrna
transcript
upon
activ
point
tcr
vb
famili
quantifi
use
either
flowcytometri
measur
tcr
vb
mrna
transcript
futur
studi
show
combin
techniqu
provid
biolog
meaning
data
context
immunomonitor
individu
tcr
variabl
profil
obtain
tcr
vfamili
depict
function
length
peak
repres
three
base
pair
bp
code
one
amino
acid
aa
residu
gener
human
healthi
subject
aa
identifi
profil
area
entir
analysi
estim
tcr
va
vb
famili
area
curv
individu
peak
express
percentag
entir
area
briefli
total
rna
extract
revers
transcrib
cdna
individu
tcr
famili
amplifi
use
common
primer
constant
region
tcr
supplement
primer
specif
tcr
famili
figur
tcr
vbspecif
primer
predominantli
implement
tcr
fingerprint
tcr
va
primer
also
report
use
clinic
studi
point
individu
tcr
va
vb
famili
describ
posit
amplicon
subject
elong
reaction
use
dyelabel
primer
cover
constant
region
tcr
allow
amplifi
tcr
vb
altern
va
famili
exact
length
product
determin
use
dnasequenc
appropri
intern
bp
length
standard
label
differ
dye
compar
primer
use
elong
reaction
instanc
polyclon
oligoclon
monoclon
tcr
determin
figur
monoclon
confirm
dna
sequenc
analysi
sinc
singl
peak
given
tcr
v
famili
state
popul
share
ident
length
region
may
possibl
singl
peak
defin
length
code
differ
amino
acid
residu
thu
monoclon
confirm
dna
sequenc
analysi
gaug
differ
fingerprint
allow
snapshot
tcr
composit
given
time
point
howev
compar
approach
often
use
clinic
context
eg
patient
undergo
immunotherapi
individu
tcr
va
vb
repertoir
may
depict
twodimension
imag
figur
report
tcr
length
individu
tcr
famili
length
measur
normal
healthi
subject
peak
pattern
repres
gauss
distribut
data
tcr
famili
area
curv
tcr
peak
ie
bp
aa
compil
pattern
may
depict
twodimension
ie
one
pictur
tcr
vavb
famili
altern
entir
tcr
vavb
repertoir
may
combin
singl
complex
figur
therebi
creat
tcr
va
tcr
vb
landscap
function
length
defin
number
encod
aa
area
curv
individu
peak
sake
clariti
peak
depict
differ
color
twodimension
top
threedimension
bottom
pictur
tcr
repertoir
analysi
defin
tcr
vb
spectratyp
til
line
patient
cervic
cancer
twodimension
pictur
allow
analyz
vb
famili
landscap
pictur
repres
overview
tcr
divers
singl
tcr
chain
mark
arrow
found
monoclon
recogn
autolog
tumor
cell
see
also
color
plate
section
page
altern
tcr
analysi
also
depict
landscap
ie
function
length
zaxi
vb
famili
xaxi
percentag
individu
distinct
va
vb
famili
yaxi
possibl
use
regular
excel
spreadsheet
function
altern
use
softwar
allow
describ
tcr
repertoir
time
evalu
order
compar
either
longitudin
differ
ie
pbl
tissu
sampl
collect
differ
time
point
ii
spatial
differ
ie
differ
tumor
sampl
pbl
individu
lymph
node
section
tcr
distribut
pattern
individu
va
vb
famili
use
control
sampl
control
sampl
use
individu
patient
ie
pre
postimmun
tumornorm
tissu
repres
gaussdistribut
sampl
either
pbl
healthi
blood
donor
differ
peak
va
vb
famili
calcul
compar
area
curv
test
sampl
versu
control
sampl
three
possibl
occur
pattern
ident
flat
smooth
area
tcr
landscap
occur
ii
peak
enhanc
result
overrepresent
certain
peak
yield
posit
signal
perturb
yaxi
iii
peak
diminish
ablat
result
underrepresent
peak
depict
perturb
yaxi
sake
clariti
certain
percentag
eg
overor
underrepresent
tcr
area
ie
comparison
two
sampl
depict
differ
color
figur
comparison
allow
detail
descript
comparison
entir
vavb
repertoir
howev
frequenc
individu
vb
famili
also
avail
inform
also
implement
comparison
tcr
vb
chain
would
case
includ
compar
analysi
qualiti
length
quantiti
frequenc
tcr
repertoir
figur
alter
quantit
composit
tcr
repertoir
measur
use
flowcytometri
rna
tcr
famili
use
realtim
pcr
base
quantif
individu
tcr
vb
mrna
transcript
topolog
tcr
vb
mrna
distribut
display
threedimension
tcell
transcriptom
coin
tclandscap
gener
healthi
antigenexperienc
individu
may
show
clonal
alter
even
monoclon
tcr
privat
alter
tcr
repertoir
report
number
appar
healthi
individu
identifi
tcell
popul
preferenti
monoclon
oligoclon
tcr
vb
famili
may
occur
ebv
cmvspecif
tcell
respons
reflect
immunolog
memori
previou
encount
antigen
alter
also
identifi
tcell
presum
react
common
infecti
agent
eg
cmv
due
structur
constraint
tcr
interact
nomin
mhcpeptid
ligand
tcell
respons
character
common
usag
tcr
vb
famili
common
motif
instanc
restrict
tcell
respons
target
influenza
matrix
peptid
aa
show
preferenti
usag
tcr
famili
polyclon
natur
preferenti
usag
certain
tcr
variabl
famili
may
also
present
human
popul
difficult
assess
sinc
studi
depend
either
gener
bona
fide
tcell
clone
direct
singl
mhcpeptid
complex
altern
tetramersort
tcell
instanc
tcr
chain
appear
frequent
util
tcell
recogn
human
restrict
melanomaassoci
antigen
determin
tetramersort
tcell
clone
analysi
monoclon
expans
tcell
may
indic
antigendriven
process
either
blood
tissu
sinc
monoclon
tcr
molecularli
defin
see
molecular
probe
specif
respect
region
design
individu
tcell
clone
either
trace
differ
compart
longitudin
time
patient
methodolog
use
tag
clonal
tcell
popul
autoimmun
myositi
patient
multipl
sclerosi
ms
suggest
expans
certain
tcr
vb
famili
may
associ
diseas
onset
progress
similarli
monoclon
tcell
respons
link
mhc
peptid
recognit
allow
visual
monoclon
tcr
defin
specif
situ
eg
patient
melanoma
respond
peptid
vaccin
tcr
reactiv
tcell
clone
could
demonstr
vitiligo
lesion
associ
destruct
melaninposit
cell
ie
melanoma
cell
normal
melanocyt
similar
studi
perform
track
hpvspecif
tcell
patient
cervic
cancer
specif
tcell
determin
tissu
use
fluorochromelabel
probe
realtim
pcr
use
uniqu
composit
region
tcell
clone
antigen
specif
tcell
undergo
select
process
drive
tcell
prolifer
patient
cancer
clonal
expans
may
associ
tumorsurveil
demonstr
patient
melanoma
undergo
peptid
vaccin
molecularli
defin
tcr
present
pbl
blood
abl
recogn
autolog
tumor
cell
inde
tcell
respons
involv
tumor
contain
may
mediat
effect
tcell
clone
even
singl
clonotyp
tcr
tcr
analysi
determin
patient
sever
combin
immunodefici
syndrom
scid
interest
appear
tcell
associ
skew
tcr
repertoir
low
trec
level
tcell
receptor
excis
circl
contrast
appear
tcell
associ
high
trec
level
marker
thymic
output
broaden
tcr
repertoir
particularli
patient
hiv
infect
advent
highli
activ
retrovir
therapi
haart
chang
prognosi
outcom
hiv
infect
progress
aid
clinic
present
opportunist
infect
associ
perturb
tcr
repertoir
haart
abl
restor
tcr
repertoir
thu
analysi
may
repres
valuabl
marker
compar
efficaci
novel
treatment
protocol
togeth
marker
eg
count
viral
load
determin
haart
drastic
reduc
viral
load
also
antihiv
direct
tcell
respons
order
boost
antihiv
direct
tcell
respons
haart
therapi
may
interrupt
stimul
antihiv
specif
tcell
monitor
critic
state
crucial
clinic
manag
determin
time
point
restart
haart
therapi
tcr
analysi
may
present
object
marker
studi
tcr
perturb
structur
stop
start
haart
therapi
allograft
reject
mediat
tlymphocyt
appreci
tcell
infiltr
transplant
may
repres
interest
prognost
marker
altern
repres
surrog
marker
test
novel
drug
prevent
graft
reject
tcr
analysi
studi
context
allograft
reject
toler
induct
eg
set
heart
transplant
context
allogen
hematopoiet
stem
cell
transplant
detail
analysi
tcr
usag
may
also
help
molecular
definit
effector
cell
popul
mediat
either
graftversusleukemia
graftversushost
reaction
recent
studi
suggest
tcr
analysi
may
repres
valuabl
tool
monitor
gvhd
allogen
stem
cell
transplant
dramat
clonal
expans
tcell
human
healthi
subject
report
possibl
link
common
viral
pathogen
eg
ebv
cmv
similarli
infect
influenza
lead
expans
tcr
famili
posit
individu
antiebv
respons
appar
drive
tcr
famili
infect
individu
carri
allel
recognit
link
restrict
ebvderiv
peptid
flrgraygl
tetram
complex
tcr
analysi
may
also
combin
determin
tcr
repertoir
chang
time
result
therapi
vaccin
instanc
tcell
respond
defin
antigen
exist
prior
therapeut
vaccin
tetram
base
analysi
abl
answer
question
antigenspecif
tcell
induc
vaccin
similar
differ
compar
preexist
tcell
tetramerguid
sort
follow
tcr
analysi
abl
identifi
molecular
differ
tcr
repertoir
react
nomin
antigen
use
vaccin
pathogenesi
number
diseas
still
well
understood
exact
mechan
contain
either
transform
viral
infect
cell
determin
gener
effect
adapt
tcell
respons
desir
diseas
flip
side
coin
context
cellular
immun
respons
strong
tcell
respons
mediat
autoimmun
disord
mani
paramet
exist
measur
diseas
activ
autoimmun
diseas
magnitud
cellular
immun
respons
hard
assess
particularli
molecular
target
identifi
sinc
tcr
analysi
visual
object
everi
alter
tcr
composit
may
help
defin
new
marker
diseas
activ
autoimmun
diseas
may
also
present
potenti
matrix
gaug
immunosuppress
effect
novel
drug
instanc
tcr
divers
suggest
readout
pbl
patient
suffer
sle
synovi
fluid
patient
ra
tcr
analysi
suggest
tcell
infiltr
patient
crohn
diseas
indic
antigendriven
process
recent
tcr
analysi
support
notion
tcell
play
major
role
mediat
inflamm
patient
ms
patient
guillainbarr
fisher
syndrom
shed
light
associ
psoriat
lesion
joint
inflamm
well
certain
form
polymyos
htlvinfect
addit
tcr
analysi
may
help
appreci
tcr
repertoir
individu
exposur
defin
pathogen
instanc
tcr
analysi
hiv
hiv
neg
men
highriskexposur
pathogen
show
gener
high
antigen
exposur
associ
restrict
tcell
repertoir
underlin
need
select
appropri
control
popul
tcr
repertoir
compar
healthi
control
comprehens
report
may
includ
tcell
follow
data
data
acquisit
data
analysi
absolut
cell
count
ratio
sort
absolut
count
sort
mrna
isol
cdna
transcript
qualiti
control
mrna
cdna
tcr
variabl
gene
analysi
individu
va
vb
vg
vd
gene
request
tcr
analysi
synopsi
tcr
v
famili
potenti
three
dimension
data
report
quantif
individu
tcr
famili
either
flowcytometri
see
figur
andor
measur
individu
tcr
mrna
transcript
qualiti
control
report
laboratori
address
sensit
specif
tcr
cdr
analysi
includ
data
interand
intraassay
variat
monoclon
tcr
confirm
dna
sequenc
analysi
monoclon
tcr
healthi
individu
repeat
entir
panel
includ
flowcytometri
applic
presenc
absenc
tcr
variabl
famili
note
process
tcr
analysi
compil
figur
r
compar
analysi
aid
visual
differ
tcell
pool
eg
respons
therapi
intervent
affect
cellular
immun
system
monoclon
tcr
sequenc
report
report
variabl
famili
join
region
dregion
vb
famili
exact
nucleotid
amino
acid
sequenc
region
respons
tcr
specif
flowcytometr
analysi
implement
gaug
tcr
repertoir
list
individu
tcr
vb
famili
differ
regard
qualiti
molecular
composit
quantiti
tcr
famili
report
percent
overor
underrepresent
compar
control
sampl
determin
investig
individu
patient
ie
prior
therapi
differ
anatom
compart
eg
til
versu
pbl
data
normal
healthi
control
popul
insuffici
number
tcell
may
indic
monoclon
higher
cell
input
reveal
real
pictur
figur
insuffici
sortingpur
tcell
eg
monoclon
tcr
popul
eg
tcr
famili
may
mask
polyclon
tcr
popul
contamin
tcell
popul
poor
mrna
isol
qualiti
target
popul
tissu
interest
tcr
mrna
turnov
may
associ
tcell
activ
rest
state
blood
fresh
frozen
tissu
paraffinembed
tissu
although
analysi
perform
use
paraffinembed
tissu
biopsi
synovi
fluid
cerebrospin
fluid
materi
bronchoalveolar
fluid
tcr
cdr
analysi
descript
method
visual
composit
entir
tcell
repertoir
combin
function
readout
assay
cellular
immun
system
point
repres
highli
reproduc
highthroughput
approach
gaug
tcell
repertoir
tissu
compar
analysi
aid
compar
tcr
divers
time
differ
anatom
compart
aid
establish
novel
marker
context
immunotherapi
disord
immun
system
tcr
analysi
predominantli
employ
human
diseas
tcr
analysi
also
perform
murin
diseas
model
nonhuman
primat
determin
tcr
repertoir
may
also
help
preclin
set
ie
test
differ
protein
peptid
composit
vaccin
formul
affect
cellular
immun
respons
sinc
tcell
abl
sens
singl
amino
acid
residu
differ
antigen
peptid
impact
subtl
alter
reflect
differenti
expans
tcr
famili
potenti
indic
implement
tcr
analysi
list
tabl
may
use
tetram
reagent
avail
entir
tcell
popul
examin
tcr
divers
particularli
studi
address
tcell
homeostasi
identif
tcell
malign
detect
monoclon
tcr
transcript
expans
clonal
tcell
determin
superantigen
effect
tcell
expans
certain
polyclon
vb
famili
individu
vb
famili
may
present
suffici
number
allow
flow
sort
tcell
may
repres
effector
cell
direct
cancer
cell
virusassoci
antigen
longitudin
analysi
qualiti
quantiti
peripher
tcell
patient
undergo
tcell
reconstitut
eg
highli
activ
antiretrovir
therapi
haart
patient
bone
marrow
transplant
patient
solid
organ
transplant
gaug
restor
tcell
compart
effect
haarttreat
associ
broad
tcrrepertoir
graft
monitor
bmt
differenti
graft
versu
tumor
graft
versu
host
effect
f
f
prognosi
assess
toler
solid
organ
recipi
compar
tcr
divers
within
individu
patient
differ
anatom
compart
order
compar
tcell
infiltr
tumor
inflammatori
lesion
tcell
infiltr
separ
stain
order
allow
comparison
tcr
divers
within
tcell
popul
experiment
identif
monoclon
tcr
tissu
anatom
compart
eg
lasermicrodissect
identif
monoclon
tcr
subsequ
clone
appropri
vector
system
allow
gener
tcrtransgen
tcell
util
identifi
target
antigen
interest
experiment
identif
track
clinic
relev
tcell
subset
eg
suppressor
tcell
memori
tcell
mediat
immunesurveil
tag
tcell
allow
follow
clinic
relev
tcell
subset
associ
responsenonrespons
therapi
defin
molecular
marker
analysi
preclin
analysi
assess
differ
immunogen
protein
peptid
differ
antigen
formul
alter
tcr
repertoir
vitro
may
help
gaug
differ
antigen
use
therapi
tcr
alter
may
combin
function
assay
cellular
immun
f
system
